Biodegradable Vancomycin-eluting Poly[(d,l)-lactide-co-glycolide] Nanofibres for the Treatment of Postoperative Central Nervous System Infection

Biodegradable Drug-Eluting Poly[lactic-co-glycol acid] Nanofibers for the Sustainable Delivery of Vancomycin to Brain Tissue: In Vitro and in Vivo Studies

(2013) Yuan-Yun Tseng et al.   ACS Chemical Neuroscience

Long-term drug release from electrospun fibers for in vivo inflammation prevention in the prevention of peritendinous adhesions

(2013) Changmin Hu et al.   Acta Biomaterialia

Sustainable release of carmustine from biodegradable poly[(d,l)-lactide-co-glycolide] nanofibrous membranes in the cerebral cavity:in vitroandin vivostudies

(2013) Yuan-Yun Tseng et al.   Expert Opinion on Drug Delivery

Infection following operations on the central nervous system: deconstructing the myth of the sterile field

(2012) Brian P. Walcott et al.   Neurosurgical Focus

Evaluation of Once-Daily Vancomycin against Methicillin-Resistant Staphylococcus aureus in a Hollow-Fiber Infection Model

(2011) Anthony M. Nicasio et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Vancomycin: We Can't Get There From Here

(2011) N. Patel et al.   CLINICAL INFECTIOUS DISEASES

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

(2011) Catherine Liu et al.   CLINICAL INFECTIOUS DISEASES

Effectiveness of the biophysical barriers on the peridural fibrosis of a postlaminectomy rat model: An experimental research

(2011) Mustafa Omur Kasimcan et al.   INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED

Biodegradable antibiotic delivery systems

(2011) M. El-Husseiny et al.   JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME

Antibiotic-releasing porous polymethylmethacrylate constructs for osseous space maintenance and infection control

(2010) Meng Shi et al.   BIOMATERIALS

Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health‐System Pharmacists, and the Society of Infectious Diseases Pharmacists

(2009) Michael J. Rybak et al.   CLINICAL INFECTIOUS DISEASES

Relationship between Initial Vancomycin Concentration‐Time Profile and Nephrotoxicity among Hospitalized Patients

(2009) Thomas P. Lodise et al.   CLINICAL INFECTIOUS DISEASES

The potential for nanoparticle-based drug delivery to the brain: overcoming the blood–brain barrier

(2009) Eugen Barbu et al.   Expert Opinion on Drug Delivery

Treatment of osteomyelitis and repair of bone defect by degradable bioactive borate glass releasing vancomycin

(2009) Zongping Xie et al.   JOURNAL OF CONTROLLED RELEASE

Complications of decompressive craniectomy for traumatic brain injury

(2009) Shirley I. Stiver   Neurosurgical Focus

Therapeutic Monitoring of Vancomycin in Adults

(2009) Michael J Rybak et al.   PHARMACOTHERAPY

Postoperative intracranial neurosurgery infection rates in North America versus Europe: A systematic analysis

(2008) Shearwood McClelland   AMERICAN JOURNAL OF INFECTION CONTROL

Management of brain abscess: an overview

(2008) Ranjith K. Moorthy et al.   Neurosurgical Focus

Brain abscess: analysis of results in a series of 51 patients with a combined surgical and medical approach during an 11-year period

(2008) Halit Çavuşoglu et al.   Neurosurgical Focus

Intravascular Delivery of Particulate Systems: Does Geometry Really Matter?

(2008) Paolo Decuzzi et al.   PHARMACEUTICAL RESEARCH

Postoperatively administered vancomycin reaches therapeutic concentration in the cerebral spinal fluid of neurosurgical patients

(2007) Qiang Wang et al.   SURGICAL NEUROLOGY